Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.42 |
| ▸ | HRH4 | Q9H3N8 | 4/20 | 0.41 |
| ▸ | HRH3 | Q9Y5N1 | 4/20 | 0.41 |
| ▸ | DRD1 | P21728 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.37 |
| ▸ | CDC25B | P30305 | 1/20 | 0.37 |
| ▸ | CTSL | P07711 | 1/20 | 0.37 |
| ▸ | CTSB | P07858 | 1/20 | 0.37 |
| ▸ | CTSK | P43235 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28144148 | 0.86 | MEN1 (0.37) | — | |
| SCHEMBL28145178 | 0.86 | MEN1 (0.40) | LMNATAAR1TSHR | |
| SCHEMBL28144168 | 0.83 | MEN1 (0.37) | LMNATAAR1HRH4HRH3 | |
| SCHEMBL28145344 | 0.82 | L3MBTL1 (0.38) | LMNATAAR1HRH4HRH3 | |
| SCHEMBL28145165 | 0.79 | TDP1 (0.51) | LMNAHRH3DRD1TSHR | |
| SCHEMBL28290953 | 0.78 | LMNA (0.41) | LMNATAAR1HRH4HRH3DRD1 | |
| SCHEMBL28145201 | 0.78 | SLC6A2 (0.43) | TAAR1 | |
| SCHEMBL18936088 | 0.76 | LMNA (0.48) | LMNATAAR1HRH4HRH3DRD1 | |
| SCHEMBL3143177 | 0.75 | LMNA (0.55) | LMNATAAR1HRH4HRH3DRD1 | |
| SCHEMBL23544405 | 0.72 | LMNA (0.43) | LMNATAAR1HRH4HRH3DRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106572659-A | Noxious arthropod control agent containing amide compound | 住友化学株式会社 | 2017-04-19 | — | — | CN | disclosed |